Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NINTEDANIB Cause Chronic kidney disease? 33 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Chronic kidney disease have been filed in association with NINTEDANIB. This represents 0.1% of all adverse event reports for NINTEDANIB.

33
Reports of Chronic kidney disease with NINTEDANIB
0.1%
of all NINTEDANIB reports
4
Deaths
27
Hospitalizations

How Dangerous Is Chronic kidney disease From NINTEDANIB?

Of the 33 reports, 4 (12.1%) resulted in death, 27 (81.8%) required hospitalization, and 10 (30.3%) were considered life-threatening.

Is Chronic kidney disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NINTEDANIB. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does NINTEDANIB Cause?

Diarrhoea (9,103) Nausea (4,198) Dyspnoea (3,080) Decreased appetite (2,832) Death (2,790) Weight decreased (2,628) Vomiting (2,524) Fatigue (2,511) Cough (2,193) Idiopathic pulmonary fibrosis (1,905)

What Other Drugs Cause Chronic kidney disease?

OMEPRAZOLE (35,759) ESOMEPRAZOLE (35,281) LANSOPRAZOLE (32,517) PANTOPRAZOLE (28,127) DEXLANSOPRAZOLE (15,973) EMTRICITABINE\TENOFOVIR DISOPROXIL (10,248) TENOFOVIR DISOPROXIL (7,230) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (5,861) RABEPRAZOLE (4,773) ESOMEPRAZOLE\NAPROXEN (2,714)

Which NINTEDANIB Alternatives Have Lower Chronic kidney disease Risk?

NINTEDANIB vs NINTEDANIB ESYLATE NINTEDANIB vs NIRAPARIB NINTEDANIB vs NIRMATRELVIR\RITONAVIR NINTEDANIB vs NIROGACESTAT NINTEDANIB vs NIROGACESTAT HYDROBROMIDE

Related Pages

NINTEDANIB Full Profile All Chronic kidney disease Reports All Drugs Causing Chronic kidney disease NINTEDANIB Demographics